Formel Labs Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 24.17 Cr
as on 05-11-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 55.00 Cr
as on 05-11-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 62.83%
(FY 2023)
About Formel Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 24.17 Cr.
The company currently has active open charges totaling ₹55.00 Cr.
Dandamudi Anitha, Raviprasad Talluru, Venkat Dandamudi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290TG2020PTC141247
- Company No.
141247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Formel Labs?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dandamudi Anitha | Managing Director | 30-Jun-2020 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkat Dandamudi | Director | 30-Jun-2020 | Current |
Raviprasad Talluru | Director | 30-Jun-2020 | Current |
Srikrishna Vankayalapati | Director | 30-Jun-2020 | Current |
Sricharan Damavarapu | Director | 30-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Formel Labs.
Formel Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Formel Labs?
In 2023, Formel Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bollineni Castings And Steel Private LimitedActive 27 years 3 months
Raviprasad Talluru is a mutual person
- Anitha Housing Private LimitedActive 17 years 10 months
Dandamudi Anitha and Raviprasad Talluru are mutual person
- Krishna Institute Of Medical Sciences LimitedActive 51 years 4 months
Dandamudi Anitha is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 13 Jul 2023 | ₹55.00 Cr | Open |
How Many Employees Work at Formel Labs?
Formel Labs has a workforce of 24 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Formel Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Formel Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.